Inhibition of CXCL8/CXCR2 binding can lead to cell cycle arrest in G0/G1 phase, inhibition of AML cell proliferation, inhibition of AKT phosphorylation, and cell apoptosis. Here, AKT1 is linked to acute myeloid leukemia.